APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icosapent Ethyl Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Icosapent Ethyl Drugs Industry Research Report 2026

28 December 2025139 pages

Choose your research edition.

Industry ResearchIcosapent Ethyl Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Icosapent Ethyl Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Icosapent Ethyl Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icosapent Ethyl Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Icosapent Ethyl Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Icosapent Ethyl Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Icosapent Ethyl Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Icosapent Ethyl Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Icosapent Ethyl Drugs include Sichuan Gowell Pharmaceutical, Humanwell Puracap Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical, Chengdu Suncadia Medicine, Zydus, Woodward Pharma, Teva and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Icosapent Ethyl Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Icosapent Ethyl Drugs Market by Company

Sichuan Gowell Pharmaceutical

Humanwell Puracap Pharmaceuticals

Qilu Pharmaceutical

Jiangsu Wangao Pharmaceutical

Chengdu Suncadia Medicine

Zydus

Woodward Pharma

Teva

Sun Pharma

Strides Pharma

PuraCap Pharmaceuticals

Mankind Pharma

Hikma

GLW Pharma

Dr. Reddy's Laboratories

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Amarin Pharmaceuticals

Icosapent Ethyl Drugs Segment by Type

Single Drug

Combination Drug

Icosapent Ethyl Drugs Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Icosapent Ethyl Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icosapent Ethyl Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icosapent Ethyl Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icosapent Ethyl Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Icosapent Ethyl Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Icosapent Ethyl Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Icosapent Ethyl Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Icosapent Ethyl Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Icosapent Ethyl Drugs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Icosapent Ethyl Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Icosapent Ethyl Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Icosapent Ethyl Drugs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Icosapent Ethyl Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Icosapent Ethyl Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Icosapent Ethyl Drugs, Product Type & Application Table 14. Global Icosapent Ethyl Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Icosapent Ethyl Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sichuan Gowell Pharmaceutical Company Information Table 19. Sichuan Gowell Pharmaceutical Business Overview Table 20. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 22. Sichuan Gowell Pharmaceutical Recent Developments Table 23. Humanwell Puracap Pharmaceuticals Company Information Table 24. Humanwell Puracap Pharmaceuticals Business Overview Table 25. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 27. Humanwell Puracap Pharmaceuticals Recent Developments Table 28. Qilu Pharmaceutical Company Information Table 29. Qilu Pharmaceutical Business Overview Table 30. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 32. Qilu Pharmaceutical Recent Developments Table 33. Jiangsu Wangao Pharmaceutical Company Information Table 34. Jiangsu Wangao Pharmaceutical Business Overview Table 35. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 37. Jiangsu Wangao Pharmaceutical Recent Developments Table 38. Chengdu Suncadia Medicine Company Information Table 39. Chengdu Suncadia Medicine Business Overview Table 40. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio Table 42. Chengdu Suncadia Medicine Recent Developments Table 43. Zydus Company Information Table 44. Zydus Business Overview Table 45. Zydus Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Zydus Icosapent Ethyl Drugs Product Portfolio Table 47. Zydus Recent Developments Table 48. Woodward Pharma Company Information Table 49. Woodward Pharma Business Overview Table 50. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Woodward Pharma Icosapent Ethyl Drugs Product Portfolio Table 52. Woodward Pharma Recent Developments Table 53. Teva Company Information Table 54. Teva Business Overview Table 55. Teva Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Teva Icosapent Ethyl Drugs Product Portfolio Table 57. Teva Recent Developments Table 58. Sun Pharma Company Information Table 59. Sun Pharma Business Overview Table 60. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sun Pharma Icosapent Ethyl Drugs Product Portfolio Table 62. Sun Pharma Recent Developments Table 63. Strides Pharma Company Information Table 64. Strides Pharma Business Overview Table 65. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Strides Pharma Icosapent Ethyl Drugs Product Portfolio Table 67. Strides Pharma Recent Developments Table 68. PuraCap Pharmaceuticals Company Information Table 69. PuraCap Pharmaceuticals Business Overview Table 70. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 72. PuraCap Pharmaceuticals Recent Developments Table 73. Mankind Pharma Company Information Table 74. Mankind Pharma Business Overview Table 75. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Mankind Pharma Icosapent Ethyl Drugs Product Portfolio Table 77. Mankind Pharma Recent Developments Table 78. Hikma Company Information Table 79. Hikma Business Overview Table 80. Hikma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hikma Icosapent Ethyl Drugs Product Portfolio Table 82. Hikma Recent Developments Table 83. GLW Pharma Company Information Table 84. GLW Pharma Business Overview Table 85. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. GLW Pharma Icosapent Ethyl Drugs Product Portfolio Table 87. GLW Pharma Recent Developments Table 88. Dr. Reddy's Laboratories Company Information Table 89. Dr. Reddy's Laboratories Business Overview Table 90. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio Table 92. Dr. Reddy's Laboratories Recent Developments Table 93. Ascent Pharmaceuticals Company Information Table 94. Ascent Pharmaceuticals Business Overview Table 95. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 97. Ascent Pharmaceuticals Recent Developments Table 98. Apotex Company Information Table 99. Apotex Business Overview Table 100. Apotex Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Apotex Icosapent Ethyl Drugs Product Portfolio Table 102. Apotex Recent Developments Table 103. Amneal Pharmaceuticals Company Information Table 104. Amneal Pharmaceuticals Business Overview Table 105. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 107. Amneal Pharmaceuticals Recent Developments Table 108. Amarin Pharmaceuticals Company Information Table 109. Amarin Pharmaceuticals Business Overview Table 110. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 112. Amarin Pharmaceuticals Recent Developments Table 113. Global Icosapent Ethyl Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Icosapent Ethyl Drugs Sales by Region (2021-2026) & (K Units) Table 115. Global Icosapent Ethyl Drugs Sales Market Share by Region (2021-2026) Table 116. Global Icosapent Ethyl Drugs Sales by Region (2027-2032) & (K Units) Table 117. Global Icosapent Ethyl Drugs Sales Market Share by Region (2027-2032) Table 118. Global Icosapent Ethyl Drugs Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2021-2026) Table 120. Global Icosapent Ethyl Drugs Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2027-2032) Table 122. North America Icosapent Ethyl Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 124. North America Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 125. North America Icosapent Ethyl Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Icosapent Ethyl Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Icosapent Ethyl Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 129. Europe Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 130. Europe Icosapent Ethyl Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Icosapent Ethyl Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Icosapent Ethyl Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific Icosapent Ethyl Drugs Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Icosapent Ethyl Drugs Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Icosapent Ethyl Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 139. South America Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 140. South America Icosapent Ethyl Drugs Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Icosapent Ethyl Drugs Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 148. Global Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 149. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026) Table 150. Global Icosapent Ethyl Drugs Sales Market Share by Type (2027-2032) Table 151. Global Icosapent Ethyl Drugs Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Icosapent Ethyl Drugs Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2026) Table 154. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2027-2032) Table 155. Global Icosapent Ethyl Drugs Price by Type (2021-2026) & (US$/Unit) Table 156. Global Icosapent Ethyl Drugs Price by Type (2027-2032) & (US$/Unit) Table 157. Global Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 158. Global Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 159. Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026) Table 160. Global Icosapent Ethyl Drugs Sales Market Share by Application (2027-2032) Table 161. Global Icosapent Ethyl Drugs Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Icosapent Ethyl Drugs Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2026) Table 164. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2027-2032) Table 165. Global Icosapent Ethyl Drugs Price by Application (2021-2026) & (US$/Unit) Table 166. Global Icosapent Ethyl Drugs Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Icosapent Ethyl Drugs Distributors List Table 170. Icosapent Ethyl Drugs Customers List Table 171. Icosapent Ethyl Drugs Industry Trends Table 172. Icosapent Ethyl Drugs Industry Drivers Table 173. Icosapent Ethyl Drugs Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Icosapent Ethyl Drugs Product Image Figure 5. Global Icosapent Ethyl Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Icosapent Ethyl Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Icosapent Ethyl Drugs Sales (2021-2032) & (K Units) Figure 8. Global Icosapent Ethyl Drugs Average Price (US$/Unit) & (2021-2032) Figure 9. Single Drug Product Image Figure 10. Combination Drug Product Image Figure 11. Retail Pharmacy Product Image Figure 12. Online Pharmacy Product Image Figure 13. Hospital Pharmacy Product Image Figure 14. Global Icosapent Ethyl Drugs Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Icosapent Ethyl Drugs, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Icosapent Ethyl Drugs Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Icosapent Ethyl Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Icosapent Ethyl Drugs Sales by Region in 2025 Figure 20. Global Icosapent Ethyl Drugs Revenue by Region in 2025 Figure 21. North America Icosapent Ethyl Drugs Market Size by Country in 2025 Figure 22. North America Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 23. North America Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2032) Figure 24. United States Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Icosapent Ethyl Drugs Market Size by Country in 2025 Figure 28. Europe Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 29. Europe Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2032) Figure 30. Germany Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Icosapent Ethyl Drugs Market Size by Country in 2025 Figure 41. Asia Pacific Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2032) Figure 43. China Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Icosapent Ethyl Drugs Market Size by Country in 2025 Figure 52. South America Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 53. South America Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2032) Figure 54. Brazil Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Icosapent Ethyl Drugs Market Size by Country in 2025 Figure 59. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2032) Figure 61. Egypt Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Icosapent Ethyl Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2032) Figure 67. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2032) Figure 68. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2021-2032) Figure 69. Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2032) Figure 70. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2032) Figure 71. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2021-2032) Figure 72. Icosapent Ethyl Drugs Value Chain Figure 73. Icosapent Ethyl Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Icosapent Ethyl Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Single Drug
  • Combination Drug
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Sichuan Gowell Pharmaceutical
  • Humanwell Puracap Pharmaceuticals
  • Qilu Pharmaceutical
  • Jiangsu Wangao Pharmaceutical
  • Chengdu Suncadia Medicine
  • Zydus
  • Woodward Pharma
  • Teva
  • Sun Pharma
  • Strides Pharma
  • PuraCap Pharmaceuticals
  • Mankind Pharma
  • Hikma
  • GLW Pharma
  • Dr. Reddy's Laboratories
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Amarin Pharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Icosapent Ethyl Drugs Market Size (2021-2032)
  4. 2.2.2 Global Icosapent Ethyl Drugs Sales (2021-2032)
  5. 2.2.3 Global Icosapent Ethyl Drugs Market Average Price (2021-2032)
  6. 2.3 Icosapent Ethyl Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Single Drug
  9. 2.3.3 Combination Drug
  10. 2.4 Icosapent Ethyl Drugs by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Retail Pharmacy
  13. 2.4.3 Online Pharmacy
  14. 2.4.4 Hospital Pharmacy
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Icosapent Ethyl Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Icosapent Ethyl Drugs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Icosapent Ethyl Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Icosapent Ethyl Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Icosapent Ethyl Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Icosapent Ethyl Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Icosapent Ethyl Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Icosapent Ethyl Drugs, Established Date
  9. 3.9 Global Icosapent Ethyl Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sichuan Gowell Pharmaceutical
  2. 4.1.1 Sichuan Gowell Pharmaceutical Company Information
  3. 4.1.2 Sichuan Gowell Pharmaceutical Business Overview
  4. 4.1.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  6. 4.1.5 Sichuan Gowell Pharmaceutical Recent Developments
  7. 4.2 Humanwell Puracap Pharmaceuticals
  8. 4.2.1 Humanwell Puracap Pharmaceuticals Company Information
  9. 4.2.2 Humanwell Puracap Pharmaceuticals Business Overview
  10. 4.2.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  12. 4.2.5 Humanwell Puracap Pharmaceuticals Recent Developments
  13. 4.3 Qilu Pharmaceutical
  14. 4.3.1 Qilu Pharmaceutical Company Information
  15. 4.3.2 Qilu Pharmaceutical Business Overview
  16. 4.3.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  18. 4.3.5 Qilu Pharmaceutical Recent Developments
  19. 4.4 Jiangsu Wangao Pharmaceutical
  20. 4.4.1 Jiangsu Wangao Pharmaceutical Company Information
  21. 4.4.2 Jiangsu Wangao Pharmaceutical Business Overview
  22. 4.4.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  24. 4.4.5 Jiangsu Wangao Pharmaceutical Recent Developments
  25. 4.5 Chengdu Suncadia Medicine
  26. 4.5.1 Chengdu Suncadia Medicine Company Information
  27. 4.5.2 Chengdu Suncadia Medicine Business Overview
  28. 4.5.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio
  30. 4.5.5 Chengdu Suncadia Medicine Recent Developments
  31. 4.6 Zydus
  32. 4.6.1 Zydus Company Information
  33. 4.6.2 Zydus Business Overview
  34. 4.6.3 Zydus Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Zydus Icosapent Ethyl Drugs Product Portfolio
  36. 4.6.5 Zydus Recent Developments
  37. 4.7 Woodward Pharma
  38. 4.7.1 Woodward Pharma Company Information
  39. 4.7.2 Woodward Pharma Business Overview
  40. 4.7.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Woodward Pharma Icosapent Ethyl Drugs Product Portfolio
  42. 4.7.5 Woodward Pharma Recent Developments
  43. 4.8 Teva
  44. 4.8.1 Teva Company Information
  45. 4.8.2 Teva Business Overview
  46. 4.8.3 Teva Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Teva Icosapent Ethyl Drugs Product Portfolio
  48. 4.8.5 Teva Recent Developments
  49. 4.9 Sun Pharma
  50. 4.9.1 Sun Pharma Company Information
  51. 4.9.2 Sun Pharma Business Overview
  52. 4.9.3 Sun Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sun Pharma Icosapent Ethyl Drugs Product Portfolio
  54. 4.9.5 Sun Pharma Recent Developments
  55. 4.10 Strides Pharma
  56. 4.10.1 Strides Pharma Company Information
  57. 4.10.2 Strides Pharma Business Overview
  58. 4.10.3 Strides Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Strides Pharma Icosapent Ethyl Drugs Product Portfolio
  60. 4.10.5 Strides Pharma Recent Developments
  61. 4.11 PuraCap Pharmaceuticals
  62. 4.11.1 PuraCap Pharmaceuticals Company Information
  63. 4.11.2 PuraCap Pharmaceuticals Business Overview
  64. 4.11.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  66. 4.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 4.12 Mankind Pharma
  68. 4.12.1 Mankind Pharma Company Information
  69. 4.12.2 Mankind Pharma Business Overview
  70. 4.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Mankind Pharma Icosapent Ethyl Drugs Product Portfolio
  72. 4.12.5 Mankind Pharma Recent Developments
  73. 4.13 Hikma
  74. 4.13.1 Hikma Company Information
  75. 4.13.2 Hikma Business Overview
  76. 4.13.3 Hikma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hikma Icosapent Ethyl Drugs Product Portfolio
  78. 4.13.5 Hikma Recent Developments
  79. 4.14 GLW Pharma
  80. 4.14.1 GLW Pharma Company Information
  81. 4.14.2 GLW Pharma Business Overview
  82. 4.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 GLW Pharma Icosapent Ethyl Drugs Product Portfolio
  84. 4.14.5 GLW Pharma Recent Developments
  85. 4.15 Dr. Reddy's Laboratories
  86. 4.15.1 Dr. Reddy's Laboratories Company Information
  87. 4.15.2 Dr. Reddy's Laboratories Business Overview
  88. 4.15.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio
  90. 4.15.5 Dr. Reddy's Laboratories Recent Developments
  91. 4.16 Ascent Pharmaceuticals
  92. 4.16.1 Ascent Pharmaceuticals Company Information
  93. 4.16.2 Ascent Pharmaceuticals Business Overview
  94. 4.16.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  96. 4.16.5 Ascent Pharmaceuticals Recent Developments
  97. 4.17 Apotex
  98. 4.17.1 Apotex Company Information
  99. 4.17.2 Apotex Business Overview
  100. 4.17.3 Apotex Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Apotex Icosapent Ethyl Drugs Product Portfolio
  102. 4.17.5 Apotex Recent Developments
  103. 4.18 Amneal Pharmaceuticals
  104. 4.18.1 Amneal Pharmaceuticals Company Information
  105. 4.18.2 Amneal Pharmaceuticals Business Overview
  106. 4.18.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  108. 4.18.5 Amneal Pharmaceuticals Recent Developments
  109. 4.19 Amarin Pharmaceuticals
  110. 4.19.1 Amarin Pharmaceuticals Company Information
  111. 4.19.2 Amarin Pharmaceuticals Business Overview
  112. 4.19.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  114. 4.19.5 Amarin Pharmaceuticals Recent Developments
5 Global Icosapent Ethyl Drugs Market Scenario by Region
  1. 5.1 Global Icosapent Ethyl Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Icosapent Ethyl Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Icosapent Ethyl Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Icosapent Ethyl Drugs Sales by Region: 2027-2032
  5. 5.3 Global Icosapent Ethyl Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Icosapent Ethyl Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Icosapent Ethyl Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Icosapent Ethyl Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Icosapent Ethyl Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Icosapent Ethyl Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Icosapent Ethyl Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Icosapent Ethyl Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Icosapent Ethyl Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Icosapent Ethyl Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Icosapent Ethyl Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Icosapent Ethyl Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Icosapent Ethyl Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Icosapent Ethyl Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Icosapent Ethyl Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Icosapent Ethyl Drugs Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Icosapent Ethyl Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Icosapent Ethyl Drugs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Icosapent Ethyl Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Icosapent Ethyl Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Icosapent Ethyl Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Icosapent Ethyl Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Icosapent Ethyl Drugs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Icosapent Ethyl Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Icosapent Ethyl Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Icosapent Ethyl Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Icosapent Ethyl Drugs Value Chain Analysis
  2. 8.1.1 Icosapent Ethyl Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Icosapent Ethyl Drugs Production Mode & Process
  5. 8.2 Icosapent Ethyl Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Icosapent Ethyl Drugs Distributors
  8. 8.2.3 Icosapent Ethyl Drugs Customers
9 Global Icosapent Ethyl Drugs Analyzing Market Dynamics
  1. 9.1 Icosapent Ethyl Drugs Industry Trends
  2. 9.2 Icosapent Ethyl Drugs Industry Drivers
  3. 9.3 Icosapent Ethyl Drugs Industry Opportunities and Challenges
  4. 9.4 Icosapent Ethyl Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst